← 返回

腹水中的脂质摄取驱动卵巢癌中 NK 细胞代谢功能障碍

英文原题:Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer.

查看英文原题

Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer.

PubMed 2025/05/09(内容时间) Sci Immunol Q1 · IF 16.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

高级别浆液性卵巢癌(HGSOC)仍是一个亟待满足的临床需求,超过70%的患者在就诊时已存在转移性疾病。许多患者出现大量腹水,腹水促进转移并与治疗反应差和生存期短相关。免疫治疗试验显示出有限的效果,凸显了更好地理解HGSOC免疫学的必要性。在此,我们分析了HGSOC患者的细胞毒性淋巴细胞[自然杀伤(NK)细胞、T细胞和固有T细胞],观察到原发部位和转移部位普遍存在功能障碍。尽管腹水营养丰富,但对所有淋巴细胞亚群均具有免疫抑制作用。NK细胞功能障碍由极性脂质摄取驱动,并伴有脂质储存的失调。磷脂酰胆碱是一种关键的免疫抑制代谢物,破坏NK细胞膜有序性和细胞毒性。通过SR-B1阻断脂质摄取可保护NK细胞在腹水中的抗肿瘤功能。这些发现为HGSOC的免疫抑制提供了见解,并对未来免疫治疗的设计具有重要意义。

展开英文摘要原文

High-grade serous ovarian cancer (HGSOC) remains an urgent unmet clinical need, with more than 70% of patients presenting with metastatic disease. Many patients develop large volumes of ascites, which promotes metastasis and is associated with poor therapeutic response and survival. Immunotherapy trials have shown limited success, highlighting the need to better understand HGSOC immunology.

Here, we analyzed cytotoxic lymphocytes [natural killer (NK), T, and innate T cells] from patients with HGSOC and observed widespread dysfunction across primary and metastatic sites. Although nutrient rich, ascites was immunosuppressive for all lymphocyte subsets.

NK cell dysfunction was driven by uptake of polar lipids, with associated dysregulation in lipid storage. Phosphatidylcholine was a key immunosuppressive metabolite, disrupting NK cell membrane order and cytotoxicity. Blocking lipid uptake through SR-B1 protected NK cell antitumor functions in ascites.

These findings offer insights into immune suppression in HGSOC and have important implications for the design of future immunotherapies.

论文信息

作者
Slattery K、Yao CH、Mylod E、Scanlan J、Scott B、Crowley JP、McGowan O、McManus G
单位
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.Ireland
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Science immunology2025 May 9
原文标识
PubMed 40344087 · DOI 10.1126/sciimmunol.adr4795